37344 Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3042. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: Section 

337 of the Tariff Act of 1930 provides 

that, if the Commission finds a 

violation, it shall exclude the articles 

concerned from the United States: 

unless, after considering the effect of such 

exclusion upon the public health and 

welfare, competitive conditions in the United 

States economy, the production of like or 

directly competitive articles in the United 

States, and United States consumers, it finds 

that such articles should not be excluded 

from entry. 

19 U.S.C. 1337(d)(1). A similar 

provision applies to cease and desist 

orders. 19 U.S.C. 1337(f)(1). 

The Commission is soliciting 

submissions on public interest issues 

raised by the recommended relief 

should the Commission find a violation, 

specifically: A limited exclusion order 

directed to certain chemical mechanical 

planarization (‘‘CMP’’) slurries and 

components thereof, including colloidal 

silica imported, sold for importation, 

and/or sold after importation by 

respondents DuPont de Nemours, Inc. of 

Wilmington, Delaware; Rohm and Haas 

Electronic Materials CMP, LLC of 

Newark, Delaware; Rohm and Haas 

Electronic Materials CMP Asia Inc. (d/ 

b/a Rohm and Haas Electronic Materials 

CMP Asia Inc., Taiwan Branch (U.S.A.)) 

of Taoyuan City, Taiwan; Rohm and 

Haas Electronic Materials Asia-Pacific 

Co., Ltd. of Miaoli, Taiwan; Rohm and 

Haas Electronic Materials K.K. of Tokyo, 

Japan; and Rohm and Haas Electronic 

Materials LLC of Marlborough, 

Massachusetts (collectively, 

‘‘Respondents’’); and cease and desist 

orders directed to Respondents. Parties 

are to file public interest submissions 

pursuant to 19 CFR 210.50(a)(4). 

The Commission is interested in 

further development of the record on 

the public interest in this investigation. 

Accordingly, members of the public are 

invited to file submissions of no more 

than five (5) pages, inclusive of 

attachments, concerning the public 

interest in light of the ALJ’s 

Recommended Determination on 

Remedy and Bonding issued in this 

investigation on July 8, 2021. Comments 

should address whether issuance of the 

recommended remedial orders in this 

investigation, should the Commission 

find a violation, would affect the public 

health and welfare in the United States, 

competitive conditions in the United 

States economy, the production of like 

or directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the recommended 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on 

August 9, 2021. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 

(March 19, 2020). Submissions should 

refer to the investigation number (‘‘Inv. 

No. 337–TA–1204’’) in a prominent 

place on the cover page and/or the first 

page. (See Handbook for Electronic 

Filing Procedures, https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf.). Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in Part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: July 12, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–15087 Filed 7–14–21; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

Notice of Receipt of Complaint; 

Solicitation of Comments Relating to 

the Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission has received a complaint 

entitled Certain Flocked Swabs, 

Products Containing Flocked Swabs, 

and Methods of Using Same, DN 3559; 

the Commission is soliciting comments 

on any public interest issues raised by 

the complaint or complainant’s filing 

pursuant to the Commission’s Rules of 

Practice and Procedure. 

FOR FURTHER INFORMATION CONTACT: Lisa 

R. Barton, Secretary to the Commission, 

U.S. International Trade Commission, 

500 E Street SW, Washington, DC 

20436, telephone (202) 205–2000. The 

public version of the complaint can be 

accessed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices 37345 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

For help accessing EDIS, please email 

EDIS3Help@usitc.gov. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server at United 

States International Trade Commission 

(USITC) at https://www.usitc.gov. The 

public record for this investigation may 

be viewed on the Commission’s 

Electronic Document Information 

System (EDIS) at https://edis.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission has received a complaint 

and a submission pursuant to § 210.8(b) 

of the Commission’s Rules of Practice 

and Procedure filed on behalf of Copan 

Italia S.P.A. and Copan Industries, Inc. 

on July 9, 2021. The complaint alleges 

violations of section 337 of the Tariff 

Act of 1930 (19 U.S.C. 1337) in the 

importation into the United States, the 

sale for importation, and the sale within 

the United States after importation of 

certain flocked swabs, products 

containing flocked swabs, and methods 

of using same. The complainant names 

as respondents: Han Chang Medic of 

South Korea; Wuxi NEST Biotechnology 

Co. Ltd. of China; NEST Scientific Inc. 

of Rahway, NJ; NEST Scientific USA of 

Rahway, NJ; Miraclean Technology Co., 

Ltd. of China; Huanchenyang 

(Shenzhen) Technology Co., Ltd. of 

China; HCY USA, LLC of Houston, TX; 

Vectornate Korea Ltd. of South Korea; 

Vectornate USA, Inc. of Mahwah, NJ; 

Innovative Product Brands, Inc. of 

Highland, CA; Thomas Scientific, Inc. of 

Swedesboro, NJ; Thomas Scientific, LLC 

of Swedesboro, NJ; Stellar Scientific, 

LLC of Owings Mills, MD; Cardinal 

Health, Inc. of Dublin, OH; Ksl 

Biomedical, Inc. of Williamsville, NY; 

Ksl Diagnostics, Inc. of Williamsville, 

NY; Jiangsu Changfeng Medical Industry 

Co., Ltd. of China; No Borders Dental 

Resources, Inc., d/b/a MediDent 

Supplies of Queeen Creek, AZ; BioTeke 

Corporation (Wuxi) Co., Ltd. of China; 

Fosun Pharma USA Inc. of Princeton, 

NJ; Hunan Runmei Gene Technology 

Co., Ltd. of China; VWR International, 

LLC of Radnor, PA; Shenzhen Cleanmo 

Technology Co., Ltd. of China; Cleanmo 

International (HK) Co., Limited of Hong 

Kong; Slmp, LLC d/b/a StatLab Medical 

Products of McKinney, TX; and Avrio 

Genetics LLC d/b/a Bio Testing Supplies 

of Allentown, PA. The complainant 

requests that the Commission issue a 

general exclusion order or in the 

alternative, a limited exclusion order, 

cease and desist orders, and impose a 

bond upon respondents alleged 

infringing articles during the 60-day 

Presidential review period pursuant to 

19 U.S.C. 1337(j). 

Proposed respondents, other 

interested parties, and members of the 

public are invited to file comments on 

any public interest issues raised by the 

complaint or § 210.8(b) filing. 

Comments should address whether 

issuance of the relief specifically 

requested by the complainant in this 

investigation would affect the public 

health and welfare in the United States, 

competitive conditions in the United 

States economy, the production of like 

or directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the requested 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the requested remedial 

orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the requested 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the requested 

remedial orders would impact United 

States consumers. 

Written submissions on the public 

interest must be filed no later than by 

close of business, eight calendar days 

after the date of publication of this 

notice in the Federal Register. There 

will be further opportunities for 

comment on the public interest after the 

issuance of any final initial 

determination in this investigation. Any 

written submissions on other issues 

must also be filed by no later than the 

close of business, eight calendar days 

after publication of this notice in the 

Federal Register. Complainant may file 

replies to any written submissions no 

later than three calendar days after the 

date on which any initial submissions 

were due. No other submissions will be 

accepted, unless requested by the 

Commission. Any submissions and 

replies filed in response to this Notice 

are limited to five (5) pages in length, 

inclusive of attachments. Persons filing 

written submissions must file the 

original document electronically on or 

before the deadlines stated above. 

Submissions should refer to the docket 

number (‘‘Docket No. 3559’’) in a 

prominent place on the cover page and/ 

or the first page. (See Handbook for 

Electronic Filing Procedures, Electronic 

Filing Procedures).1 Please note the 

Secretary’s Office will accept only 

electronic filings during this time. 

Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. Persons with questions 

regarding filing should contact the 

Secretary at EDIS3Help@usitc.gov. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 


khammond on DSKJM1Z7X2PROD with NOTICES
37346 Federal Register / Vol. 86, No. 133 / Thursday, July 15, 2021 / Notices 

Issued: July 9, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–15006 Filed 7–14–21; 8:45 am] 

BILLING CODE 7020–02–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket Nos. 50–003, 50–247, 50–286, and 

72–051; NRC–2021–0125] 

Holtec Decommissioning International, 

LLC; Indian Point Nuclear Generating, 

Unit Nos. 1, 2, and 3; Post-Shutdown 

Decommissioning Activities Report 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Public meeting and request for 

comment. 

SUMMARY: On June 24, 2021, the U.S. 

Nuclear Regulatory Commission (NRC) 

noticed receipt of, and solicited public 

comments on, the post-shutdown 

decommissioning activities report 

(PSDAR) for the Indian Point Nuclear 

Generating, Unit Nos. 1, 2, and 3 (Indian 

Point Energy Center (IPEC)), submitted 

by Holtec Decommissioning 

International, LLC (HDI). The PSDAR, 

which includes the site-specific 

decommissioning cost estimate (DCE), 

provides an overview of HDI’s planned 

activities, schedule, projected costs, and 

environmental impacts for the 

decommissioning of the IPEC. The NRC 

will hold a public meeting to discuss 

the PSDAR and DCE and to receive 

comments. 

DATES: The public meeting will be held 

on Thursday, July 29, 2021, from 6:00 

p.m. until 9:00 p.m. (ET), at the Sleepy 

Hollow Hotel and Conference Center 

(previously the DoubleTree Hotel), 

located at 455 South Broadway, in 

Tarrytown, NY. Submit comments by 

October 22, 2021. Comments received 

after this date will be considered, if it 

is practical to do so, but the NRC is able 

to ensure consideration only for 

comments received on or before this 

date. 

ADDRESSES: You may submit comments 

by any of the following methods; 

however, the NRC encourages electronic 

comment submission through the 

Federal Rulemaking website: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0125. Address 

questions about Docket IDs in 

Regulations.gov to Stacy Schumann; 

telephone: 301–415–0624; email: 

Stacy.Schumann@nrc.gov. For technical 

questions, contact the individual listed 

in the FOR FURTHER INFORMATION

CONTACT section of this document. 

• Mail comments to: Office of 

Administration, Mail Stop: TWFN–7– 

A60M, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001, ATTN: Program Management, 

Announcements and Editing Staff. 

For additional direction on obtaining 

information and submitting comments, 

see ‘‘Obtaining Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: 

Richard V. Guzman, Office of Nuclear 

Reactor Regulation, U.S. Nuclear 

Regulatory Commission, Washington, 

DC 20555–0001, telephone: 301–415– 

1030; email: Richard.Guzman@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to Docket ID NRC–2021– 

0125 when contacting the NRC about 

the availability of information for this 

action. You may obtain publicly 

available information related to this 

action by any of the following methods: 

• Federal Rulemaking Website: Go to 

https://www.regulations.gov and search 

for Docket ID NRC–2021–0125. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publicly 

available documents online in the 

ADAMS Public Documents collection at 

https://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘Begin Web-based ADAMS Search.’’ For 

problems with ADAMS, please contact 

the NRC’s Public Document Room (PDR) 

reference staff at 1–800–397–4209, 301– 

415–4737, or by email to pdr.resource@

nrc.gov. The IPEC PSDAR is available in 

ADAMS under Accession No. 

ML19354A698. 

• Attention: The PDR, where you may 

examine and order copies of public 

documents, is currently closed. You 

may submit your request to the PDR via 

email at pdr.resource@nrc.gov or call 1– 

800–397–4209 or 301–415–4737, 

between 8:00 a.m. and 4:00 p.m. (ET), 

Monday through Friday, except Federal 

holidays. 

B. Submitting Comments 

The NRC encourages electronic 

comment submission through the 

Federal Rulemaking website (https://

www.regulations.gov). Please include 

Docket ID NRC–2021–0125 in your 

comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at https://

www.regulations.gov as well as entering 

the comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment submissions into 

ADAMS. 

II. Discussion 

HDI has the authority to conduct 

licensed activities under Provisional 

License No. DPR–5, Renewed Facility 

License No. DPR–26, and Renewed 

Facility License No. DPR–64 for the 

IPEC, and the general license for the 

IPEC independent spent fuel storage 

installation (ISFSI). These licenses 

provide, among other things, that the 

respective facilities are subject to all 

rules, regulations, and orders of the NRC 

now or hereafter in effect. The facilities 

consist of three pressurized-water 

reactors located in Buchanan, New 

York, in Westchester County, all of 

which are permanently shutdown, and 

the ISFSI. 

On December 19, 2019, HDI submitted 

to the NRC the PSDAR for the IPEC, 

contingent upon the transfer of the IPEC 

licenses to HDI (ADAMS Accession No. 

ML19354A698). Paragraph 50.82(a)(4)(i) 

of title 10 of the Code of Federal 

Regulations (10 CFR) states that a 

PSDAR must contain a description of 

the planned decommissioning activities 

along with a schedule for their 

accomplishment, a discussion that 

provides the reasons for concluding that 

the environmental impacts associated 

with site-specific decommissioning 

activities will be bounded by 

appropriate previously issued 

environmental impact statements, and a 

site-specific DCE, including the 

projected cost of managing irradiated 

fuel. The IPEC license transfer 

transaction closed on May 28, 2021. 

Accordingly, pursuant to 10 CFR 

50.82(a)(4)(ii), the NRC noticed receipt 

of the PSDAR, including the DCE, for 

IPEC and made it available for public 

comment on June 24, 2021 (86 FR 

33383). 


khammond on DSKJM1Z7X2PROD with NOTICES